BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31423165)

  • 1. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer.
    Liu L; Yi J; Deng X; Yuan J; Zhou B; Lin Z; Zeng Z
    Oncol Lett; 2019 Aug; 18(2):1049-1056. PubMed ID: 31423165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.
    Liu L; Yi J; Yuan J; Yao T; Lin Z; Ning Y; Zeng Z
    Cancer Biomark; 2020; 28(1):1-8. PubMed ID: 32224523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
    Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
    Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.
    Deng Y; Liu L; Feng W; Lin Z; Ning Y; Luo X
    Recent Pat Anticancer Drug Discov; 2021; 16(4):533-539. PubMed ID: 34551701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.
    Liu L; Lv J; Lin Z; Ning Y; Li J; Liu P; Chen C
    Front Mol Biosci; 2021; 8():785922. PubMed ID: 35223984
    [No Abstract]   [Full Text] [Related]  

  • 6. LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
    Zeng Z; Ji N; Yi J; Lv J; Yuan J; Lin Z; Liu L; Feng X
    Cancer Biomark; 2020; 28(1):65-72. PubMed ID: 32176632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.
    Yao Y; Liu L; He W; Lin X; Zhang X; Lin Z; Zeng Z; Guo S
    Cancer Biomark; 2019; 26(4):481-489. PubMed ID: 31658044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer.
    Li H; Zhang W; Sun X; Chen J; Li Y; Niu C; Xu B; Zhang Y
    Cancer Manag Res; 2018; 10():3433-3450. PubMed ID: 30254487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
    Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
    Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer.
    Liu S; Yin H; Ji H; Zhu J; Ma R
    Exp Ther Med; 2018 Oct; 16(4):3034-3040. PubMed ID: 30214522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and clinical significance of IBP in epithelial ovarian carcinoma.
    Xu Y; Hou Y; Liu T; Lou G
    Oncol Lett; 2018 May; 15(5):6604-6610. PubMed ID: 29616123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Xie X; Yang M; Ding Y; Yu L; Chen J
    Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathology of EpCAM and EGFR in Human Epithelial Ovarian Carcinoma.
    Zheng J; Zhao L; Wang Y; Zhao S; Cui M
    Open Med (Wars); 2017 Jan; 12():39-44. PubMed ID: 28401199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis.
    Ma M; Yu N
    Onco Targets Ther; 2016; 9():1559-69. PubMed ID: 27051296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer.
    Sun X; Zhang W; Li H; Niu C; Ou Y; Song L; Zhang Y
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.